A clinician's perspective on the value of CGM for non-insulin patients

Episode overview: 

Even for those not on insulin, continuous glucose monitoring (CGM) is transforming the way HCPs approach diabetes treatment. Cher Pastore, MS, RD, CDCES, BC-ADM and guest David Doriguzzi, a Physician Assistant in endocrinology and internal medicine explore how Dexcom G7 and Stelo are reshaping diabetes management for people with type 1 diabetes, type 2 diabetes, and prediabetes. 

Together, they break down how Dexcom’s portfolio provides real-time glucose monitoring, reveals patterns invisible through traditional blood sugar monitoring, and inspires meaningful behavior change. 

David shares patient stories that demonstrate how CGM is helping individuals recognize how food, activity and medications impact their diabetes management. He also explains how CGM empowers providers to tailor diabetes education and medication strategies, especially in primary care settings with limited access to endocrinologists. 

Whether you’re managing type 1 diabetes, type 2 diabetes or on the journey to prevent it, this conversation showcases how diabetes technology like CGM can simplify treatment decisions, personalize care, and ultimately make an impact for both patients and providers. 

This guest is a paid spokesperson for Dexcom.  Fingersticks required for diabetes treatment decisions if symptoms or expectations do not match readings.  Dexcom G7 can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer.  Smart devices are sold separately. For a list of compatible smart devices, visit: dexcom.com/compatibility.  “Dexcom" refers to the Dexcom CGM.  Compatible smartphone is required to pair a new Dexcom G7 sensor with a compatible Apple Watch. To use Share/Follow the smartphone must be within 33 feet of the Dexcom G7.  The Dexcom G7 Continuous Glucose Monitoring System (Dexcom G7 System) is a real time, continuous glucose monitoring device indicated for the management of diabetes in persons aged 2 years and older. Dexcom G7 has no limitations for use in pregnancy.  G7 15 Day is only for adults 18+. 

Why CGM is crucial for people with diabetes not using insulin

For a deeper dive on this topic, visit GlucoseTech

GlucoseTech

To advance clinical knowledge and patient outcomes by providing evidence-based, clinically relevant CGM education that fits into real world practice.

Built by clinicians and healthcare educators, GlucoseTech delivers practical, evidence-based guidance you can apply immediately—without logins, paywalls, or barriers.

Learn More

Image
GT Image
Image
Glucose Tech

Expert insights for smarter CGM use

The GlucoseTech Podcast is a trusted educational resource for healthcare professionals seeking the latest insights in CGM technology. Featuring conversations with leading experts, episodes explore emerging evidence, practical patient management strategies, technology innovations, and real-world clinical experiences shaping the future of care. Designed for busy clinicians, GlucoseTech delivers concise, relevant discussions that help translate science into practice. Listen now to stay current on CGM technology.

  • Listen on spotify
  • Listen on Podcasts
  • Glucose tech
Dexcom healthcare provider

Request a representative visit or G7 15 Day or G7 samples

CGM=continuous glucose monitoring.

MAT-15649